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Abstract
In Genome-Wide Association Studies (GWAS) where multiple correlated traits have
been measured on participants, a joint analysis strategy, whereby the traits are ana-
lyzed jointly, can improve statistical power over a single-trait analysis strategy. There
are two questions of interest to be addressed when conducting a joint GWAS analysis
with multiple traits. The first question examines whether a genetic loci is significantly
associated with any of the traits being tested. The second question focuses on identify-
ing the specific trait(s) that is associated with the genetic loci. Since existing methods
primarily focus on the first question, this paper seeks to provide a complementary
method that addresses the second question. We propose a novel method, Variational
Inference for Multiple Correlated Outcomes (VIMCO), that focuses on identifying the
specific trait that is associated with the genetic loci, when performing a joint GWAS
analysis of multiple traits, while accounting for correlation among the multiple traits.
We performed extensive numerical studies and also applied VIMCO to analyze two
datasets. The numerical studies and real data analysis demonstrate that VIMCO im-
proves statistical power over single-trait analysis strategies when the multiple traits
are correlated and has comparable performance when the traits are not correlated.
∗To whom correspondence should be addressed, equal contribution.
1
1 Introduction
Genome-wide association studies (GWAS) conducted in the last decade have provided valu-
able insights into the genetic architecture underlying complex traits. GWAS are generally
performed by analyzing individual traits, although multiple related traits are often collected,
and in some cases these traits may reflect a common condition [8]. In a GWAS where mul-
tiple traits have been measured on the study individuals, a joint analysis strategy whereby
the multiple traits are analyzed jointly, offers improved statistical power when compared to
a single-trait analysis strategy, when a genetic variant is associated with one or more cor-
related phenotypes [9, 17]. A joint analysis strategy may also be useful when the different
phenotypes characterize the same underlying trait.
There are typically two questions of interest to be addressed in a joint GWAS analysis of
multiple traits. The first question addresses whether a genetic loci is significantly associated
with any of the (correlated) phenotypes being tested. The second question, focuses on the
identification of the phenotype(s) that is/are associated with the genetic loci. When multiple
continuous traits and genotype data are available from the same study individuals, a joint
GWAS analysis that addresses the first question can be performed using linear mixed models
based methods [5]. Examples of linear mixed models based methods include the multi-trait
mixed models (MTMM) proposed by [9] and the multivariate linear mixed models (mvLMM)
implemented in the Genome-wide Efficient Mixed Model Association (GEMMA) software
[20]. A central limitation of these methods is that they cannot address the second question
which seeks to identify the tested trait(s) that is/are associated with the genetic loci. Multi-
trait variable selection methods based on penalization have also been proposed in this context
[15, 11]. However, they cannot be applied to assess associations while controlling the error
rate [4].
In this paper, we propose a novel method, Variational Inference for Multiple Correlated
Outcomes (VIMCO), for joint analysis of multiple traits in GWAS that addresses the second
question. VIMCO is applicable when individual-level data on multiple traits and genotype
are available on the same study individuals. Our proposed method, can be viewed as a
complementary method to the widely-used mvLMM implemented in the GEMMA package,
in that it addresses a different but related scientific question and allows one to identify
the specific trait that is associated with the genetic loci when performing a joint analysis
of multiple traits. A variational Bayesian expectation-maximization (VBEM) algorithm
is used to ensure computational efficiency. Through extensive numerical studies and real
data analyses, we demonstrate that our proposed approach offers improved statistical power
when compared to existing single-trait analysis strategies. The remainder of this article is
organized as follows. In Section 2, we describe the model and algorithm that VIMCO uses to
perform joint analysis of multiple traits. We then illustrate the performance of VIMCO using
numerical simulations and real data analyses in Section 3 and conclude with a discussion in
Section 4.
2
2 VIMCO
2.1 Model
In this section, we describe the notation and model used for joint modeling of multiple traits
in a GWAS using VIMCO. Consider K continuous phenotypes/traits, Y1, . . . , YK , that are
measured on N individuals, where Yk is a N × 1 vector for k = 1, · · · , K. Assume that the
genome-wide genotype data consists of p SNPs given by, X1, . . . , Xp where Xj is a N × 1
vector for j = 1, · · · , p. Denote X = [X1, . . . , Xp] ∈ RN×p and Y = [Y1, . . . , YK ] ∈ RN×K .
Without loss of generality, we assume that both the phenotypes and genotypes have been
centered. We consider the following multivariate linear model:
Y = XB+ E, (1)
whereB = [β1, . . . ,βp]
⊤ ∈ Rp×K, βj = (βj1, . . . , βjK)
⊤, j = 1, . . . , p, andE = [e⊤1 , . . . , e
⊤
N ]
⊤ ∈
R
N×K . We assume that en ∼ N (0,Θ−1), where Θ is the precision matrix of E with
dimensionality K × K for individuals n = 1, · · · , N . The entries in Θ are denoted by
θst, s, t = 1, . . . , K. Under this model, the correlation in the traits (conditional on the geno-
types) is modeled by the off-diagnoal terms in Θ−1.
We are interested in identifying genetic variants that are associated with one or more
traits, which corresponds to the identification of nonzero entries in the matrixB. We consider
a spike-slab prior for B and parameterize B as a product of latent variables. Specifically,
we assume that βj = γj ◦ β˜j = (γj1β˜j1, . . . , γjKβ˜jK)
⊤, where ◦ denotes the element-wise
product and
β˜jk ∼ N (0, σ
2
βk
), γjk ∼ a
γjk
k (1− ak)
1−γjk .
Let Φ = {a1, . . . , aK , σ2β1 , . . . , σ
2
βK
,Θ} be the collection of (unknown) model parameters.
Accordingly, our probabilistic model can be reparameterized as:
Pr(Y, β˜,γ|X; Φ) = Pr(Y|X, β˜,γ; Φ)Pr(β˜,γ|X; Φ)
=
N∏
n=1
N (
p∑
j=1
Xnj
(
γj ◦ β˜j
)
,Θ−1)
p∏
j=1
K∏
k=1
[
a
γjk
k (1− ak)
1−γjkN (0, σ2βk)
]
.
With this reparameterization, to identify genetic variants that are associated with one
or more traits, we need to compute the posterior distribution of the latent variables (β˜,γ):
Pr(β˜,γ|Y,X; Φ) =
Pr(Y, β˜,γ|X; Φ)
Pr(Y|X; Φ)
=
Pr(Y, β˜,γ|X; Φ)∑
γ
∫
β˜
Pr(Y, β˜,γ|X; Φ)dβ˜
. (2)
2.2 VBEM algorithm
In this section, we describe the algorithm used for computation of the model parameters and
the posterior distribution of the latent variables (β˜,γ) in VIMCO. Exact computation of the
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posterior distribution (2) is computationally intensive due to the denominator which requires
marginalizing over the latent variables (β˜,γ). To overcome this computational intractability,
we derive a computationally efficient VBEM algorithm [1] to obtain an approximation for
the posterior distribution (2). The key idea of the VBEM algorithm is to approximate our
computationally intractable posterior distribution (2), with an approximating distribution,
which is computationally tractable. The VBEM algorithm proceeds by specifying a family of
(variational) distributions, which are parameterized by variational parameters, and choosing
the optimal approximating distribution from this family by minimizing the KL divergence
between the approximating distributions and our true posterior distribution (2) [2]. The KL
divergence can be viewed as a measure of how different the approximating distribution is
from our true posterior distribution (2). The optimal variational distribution is then used
as an approximation for the true posterior distribution (2) [1].
Let q(β˜,γ) be a candidate approximating distribution of our true posterior distribution
(2), and let Eq denote the expectation taken with respect to q(β˜,γ). We can decompose the
logarithm of the marginal likelihood as
log p(Y|X; Φ) = Lq +KL
(
q||Pr(β˜,γ|Y,X; Φ)
)
, (3)
where
Lq = Eq log
[
Pr(Y, β˜,γ|X; Φ)
q(β˜,γ)
]
KL
(
q||Pr(β˜,γ|Y,X; Φ)
)
= Eq log
[
q(β˜,γ)
Pr(β˜,γ|Y,X; Φ)
]
.
Minimizing the KL divergence with respect to the approximating distribution q(β˜,γ) is
equivalent to maximizing the evidence lower bound (ELBO) Lq. If we allow any possible
choice for q(β˜,γ), then the Kullback-Leibler divergence KL
(
q||Pr(β˜,γ|Y,X; Φ)
)
is zero if
and only if q(β˜,γ) is identical to our true posterior distribution (2) almost surely.
In order for the algorithm to be applicable to GWAS data, we require a family of distri-
butions that is sufficiently flexible to accurately approximate the true posterior distribution,
while being computationally tractable. We propose using a mean field variational family
[12], which contains distributions q(β˜,γ) of the form
q(β˜,γ) =
∏
j
∏
k
[
q(β˜jk, γjk)
]
.
The factorization used in the approximating mean field variational family of distributions
makes the VBEM algorithm computationally efficient. The approximation is expected to
perform best when the SNPs are independent and in the absence of pleiotropy. Our numerical
studies demonstrate that this approximation is sufficient in the presence of moderate SNP
correlation and moderate levels of pleiotropy. When the SNPs are highly correlated, SNP
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pruning can be used to retain a subset of SNPs that are moderately correlated, as was done
in the real data analysis.
Given this variational family of distributions, the optimal variational distribution q∗(β˜jk, γjk)
that maximizes the ELBO Lq has the form [1]
log q∗(β˜jk, γjk) = E(j′,k′)6=(j,k)
[
log Pr(Y, β˜,γ|X; Φ)
]
+ constant, (4)
where the expectation is taken with respect to all other factors q(β˜j′k′, γj′k′) for (j
′, k′) 6=
(j, k). After some derivations (details are provided in Supplementary A), the optimal varia-
tional posterior distribution is given by:∏
j
∏
k
[
α
γjk
jk (1− αjk)
1−γjkN (µjk, s
2
jk)
γjkN (0, σ2βk)
1−γjk
]
,
where the variational parameters (µjk, s
2
jk, αjk) are given by:
µjk =
∑
t θktX
⊤
j [Yt −
∑
j′ 6=j αj′tµj′tXj′]−
∑
t6=k θktαjtµjt‖Xj‖
2
θkk‖Xj‖2 +
1
σ2
βk
,
s2jk =
1
θkk‖Xj‖2 +
1
σ2
βk
,
αjk ≡ q(γjk = 1) =
1
1 + exp
(
− log ak
1−ak
+ 1
2
(
µ2
jk
s2
jk
+ log
s2
jk
σ2
βk
)) .
(5)
To solve for the variational parameters (µjk, s
2
jk, and αjk) and model parameters (Φ),
the VBEM algorithm iterates between two optimization (expectation and maximization)
steps until convergence. In the expectation step, we optimize the ELBO Lq with respect
to the variational parameters (µjk, s
2
jk and αjk), while holding the model parameters fixed,
i.e. compute variational parameters using Equation (5). In the maximization step, we
optimize the ELBO Lq with respect to the model parameters Φ while holding the variational
parameters fixed. With the optimal variational distribution, the ELBO Lq can be evaluated
in a closed form (details in Supplementary A):
Lq =−
1
2
∑
s
∑
t
θst(Ys −
∑
j
Xjαjsµjs)
⊤(Yt −
∑
j
Xjαjtµjt)
−
1
2
∑
s
θss
∑
j
X⊤j Xj [αjs(µ
2
js + s
2
js)− α
2
jsµ
2
js]
−
∑
j
∑
k
[
αjk log
αjk
ak
+ (1− αjk) log
1− αjk
1− ak
]
+
N
2
log |Θ|
+
1
2
∑
j
∑
k
αjk
(
1 + log
s2jk
σ2βk
−
µ2jk + s
2
jk
σ2βk
)
+ const.
(6)
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By taking partial derivatives of the ELBO Lq with respect to the model parameters and
setting them to zero, we can solve for the model parameters and obtain the update equations
for the maximization step:
ak =
∑
j αjk
p
,
σ2βk =
∑
j αjk(µ
2
jk + s
2
jk)∑
j αjk
,
(Θ−1)kk =
‖Yk −
∑
j Xjαjkµjk‖
2
N
+
∑
j ‖Xj‖
2
[
αjk(µ
2
jk + s
2
jk)− α
2
jkµ
2
jk
]
N
,
(Θ−1)kt =
(Yk −
∑
j Xjαjkµjk)
⊤(Yt −
∑
j Xjαjtµjt)
N
.
(7)
The VBEM algorithm iterates between the expectation (Equation (5)) and maximization
(Equation (7)) steps until convergence. Further details on the VBEM algorithm are provided
in Supplementary A.
2.3 Inference
With the estimated variational parameters (µjk, s
2
jk and αjk) and model parameters (Φ),
the posterior probability Pr(γjk = 1|Y,X; Φ) of whether genetic variant j is associated with
trait k can be estimated by α̂jk, and the local false discovery rate (lfdr) can be estimated by
1 − α̂jk. Statistical inference can be conducted by identifying SNP-trait associations while
controlling the global FDR at a fixed value. Specifically, given a cutoff for the global FDR,
the cutoff ξ for the lfdr can be computed from global FDR =
∑
j
∑
k lfdrjkI(lfdrjk≤ξ)∑
j
∑
k I(lfdrjk≤ξ)
[13].
3 Results
3.1 Simulations
We conducted numerical simulations to evaluate the performance of VIMCO. We considered
the scenario where we have K = 4 continuous traits and p = 10, 000 SNPs that were mea-
sured on N = 5, 000 individuals. For each individual, the p genotypes were simulated by first
generating a p×1 multivariate normal distribution assuming auto-regressive (AR) correlation
with parameter ρx. We then discretized each variable to a trinary variable (0, 1, 2) by assum-
ing Hardy-Weinberg equilibrium and with a minor allele frequency randomly selected from a
uniform[0.05, 0.5] distribution. The genotype correlation was varied at ρx = 0.2, 0.5, 0.8. To
generate the coefficient matrix B, for each trait, we randomly selected 1% of the SNPs to be
associated with the trait, where the effect sizes were generated from a standard normal dis-
tribution. To allow for pleiotropy where a SNP can be associated with more than one trait,
6
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Figure 1: Simulation results for evaluating null hypothesis H0a, for different ρe (increasing
levels of ρe imply increasing correlation between the traits) and genotype correlation param-
eter ρx = 0.8. Left panel: power of VIMCO and BVSR; middle panel: empirical global false
discovery rate (FDR) of VIMCO and BVSR at a nominal 0.1 level; right panel: AUC of
VIMCO, BVSR, and sLMM.
we varied the proportion of causal SNPs that was associated with more than one trait. Let
g =
∑
j I(
∑
k γjk≥2)∑
j
∑
k γjk
. The expectation of g was varied at 0, 0.15, 0.3, where increasing g reflects
increasing pleiotropy. The error matrix E was generated with rows drawn independently
from a multivariate normal distribution, with auto-regressive (AR) correlation parameter
ρe = 0.2, 0.5, 0.8. A larger value of ρe implies a higher correlation between the traits. Each
error variance was adjusted according to the prespecified heritability of h2 = 0.3.
To benchmark the performance of VIMCO, we considered both bayesian (variational
inference based bayesian variable selection regression (BVSR) [4]) and frequentist (single-
trait linear mixed model (sLMM) [19]) single-trait analysis approaches. Similar to VIMCO,
BVSR utilizes a VBEM algorithm, but can only be applied to single traits. sLMM was
implemented using the GEMMA software package. We compared the power of VIMCO
and BVSR, by considering trait-SNP associations from all traits and SNPs, and with a
global FDR controlled at 0.1. The power for VIMCO and BVSR, for the scenario where the
genotypes were strongly correlated (ρx = 0.8) and pleiotropy g = 0, is shown in the left panel
of Figure 1. When the traits showed moderate (ρe = 0.5) or strong correlation (ρe = 0.8),
VIMCO had higher statistical power than BVSR. When the traits were weakly correlated
(ρe = 0.2), VIMCO had similar power as BVSR. We also evaluated the global FDR control
for both VIMCO and BVSR. Similar to earlier papers [3], when evaluating the control of
global FDR, the SNPs were evaluated as a cluster of SNPs. i.e. rejections within the same
linkage disequilibrium (LD) block were grouped and counted as a single rejection. As shown
in the middle panel in Figure 1, both VIMCO and BVSR. had empirical false discovery rates
that were close to the nominal 0.1 level. We also compared the area under the curve (AUC) of
VIMCO, BVSR and sLMM (right panel of Figure 1). The AUC was evaluated by considering
trait-SNP associations for all traits and SNPs. The AUC of VIMCO was higher than that of
the single-trait approaches (BVSR and sLMM) when the traits showed moderate (ρe = 0.5)
7
0.0
0.2
0.4
0.6
0.8
0.2 0.5 0.8
ρE
Po
w
er
0.0
0.1
0.2
0.3
0.4
0.5
0.2 0.5 0.8
ρE
FD
R
0.7
0.8
0.9
1.0
0.2 0.5 0.8
ρE
AU
C
Method
VIMCO
BVSR
sLMM
mvLMM
Figure 2: Simulation results for evaluating null hypothesis H0b, for different ρe (increasing
levels of ρe imply increasing correlation between the traits) and genotype correlation param-
eter ρx = 0.8. Left panel: AUC of VIMCO and BVSR; middle panel: empirical global false
discovery rate (FDR) of VIMCO and BVSR, at a nominal 0.1 level; right panel: AUC of
VIMCO, BVSR, sLMM and mvLMM.
or strong correlation (ρe = 0.8). Simulations with lower genotype correlation ρx = 0.2, 0.5
and different levels of pleiotropy g are shown in Supplementary Figures B1-B3, and give
similar conclusions.
As noted earlier, mvLMM assesses a different but related null hypothesis of whether any
of the traits are associated with the genetic variants. Specifically, for the jth SNP, mvLMM
evaluates the null hypothesis H0b : βj1 = · · · = βjK = 0, while VIMCO evaluates the null
hypothesis H0a : βjk = 0 for k = 1, · · · , K traits separately. We evaluated the performance
of VIMCO for assessing the null hypothesis H0b. For evaluating the performance in assessing
the null hypothesis H0b, we performed an adhoc modification of VIMCO, BVSR and sLMM.
In this ad-hoc adaptation of VIMCO, BVSR and sLMM, we rejected the null hypothesis H0b
if H0a is rejected for any of the traits. We examined the power of VIMCO and BVSR while
controlling the global FDR at 0.1. We also compared the AUC of VIMCO, BVSR, sLMM and
mvLMM. Results for the scenario where the genotypes were strongly correlated (ρx = 0.8)
and the level of pleiotropy g = 0 are shown in Figure 2. Similar to results in evaluating H0a,
VIMCO improves statistical power and has higher AUC when the traits showed moderate
or strong correlation. Interestingly for this ad-hoc adaptation of VIMCO and BVSR, the
empirical FDR were conservative for the settings we considered (middle panel of Figure
2). We note that evaluating the null hypothesis H0b is not an intended use of VIMCO,
and this ad-hoc adaptation of VIMCO was performed in order to provide a comparison with
mvLMM. Simulations with different genotype correlation and levels of pleiotropy gave similar
conclusions (Supplementary Figures B4-B6). Simulations where genotypes were sampled
from real data, and SNP pruning was applied before applying the methods, gave similar
conclusions (Supplementary Figures B7-B8).
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3.2 Real Data Analysis
To illustrate the performance of our proposed method VIMCO, we analyzed two datasets.
The first dataset is a GWAS of four moderately correlated lipid traits from the Northern
Finland Birth Cohort 1966 (NFBC1966). The second dataset is a GWAS of three weakly
correlated eye measurements from the Singapore Indian Eye (SINDI) study [6].
3.2.1 NFBC1966
The NFBC1966 dataset consists of 10 metabolic traits and 364,590 SNPs from 5,402 in-
dividuals [16]. The 10 metabolic traits include fasting lipid levels (total cholesterol (TC),
high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglycerides (TG)), in-
flammatory marker C-reactive protein (CRP), markers of glucose homeostasis (glucose and
insulin), body mass index and blood pressure measurements (systolic and diastolic blood
pressure). Quality control of the data was performed using PLINK [14] and GCTA [18]. Indi-
viduals with missing-ness in any of the traits and with genotype missing call-rates > 5% were
excluded. We excluded SNPs with minor allele frequency < 1%, missing call-rates > 1%, or
failed Hardy-Weinberg equilibrium. After quality control filtering and SNP pruning, 172,412
SNPs from 5,123 individuals were available for analysis. We quantile-transformed each trait
to a standard normal distribution, obtained the residuals after regressing out the effects of
sex, oral contraceptives and pregnancy status, and quantile-transformed the residuals to a
standard normal distribution.
We performed analysis on the four lipid traits (TC, LDL, HDL and TG). The pairwise
pearson correlation for the four lipid traits are given in Supplementary Figure C1. Among the
four traits, TC and LDL showed the strongest correlation (corr = 0.88). Modest correlation
was also observed among the following pairs of traits: TG and TC (corr = 0.41), TG and LDL
(corr = 0.33), TG and HDL (corr = −0.40). We applied VIMCO to perform joint analysis
of the 4 traits. For comparison with the results from VIMCO, we also performed single-
trait analyses whereby each of the 4 traits were analyzed separately, using both bayesian
(variational inference based bayesian variable selection regression (BVSR) [4]) and frequentist
approaches (single-trait linear mixed model (sLMM) [19]).
For VIMCO and BVSR, we report significant SNP-trait associations at a global FDR
of 0.1. The global FDR for VIMCO and BVSR controls for multiple testing across the
multiple traits and SNPs. For sLMM, to control for multiple testing across both traits and
SNPs, we report p-values for SNP-trait associations with p-value < 1.25× 10−8 (we applied
a Bonferroni adjustment for the 4 traits to the commonly used genome-wide significance
threshold 5× 10−8).
Genomic locations of SNPs identified by VIMCO, BVSR and sLMM are shown in Figure
3. To control the global FDR at 0.1, a SNP has to have a lfdr < 0.73 and < 0.36 for
VIMCO and BVSR respectively (indicated by the horizontal red lines in the plots). VIMCO
identified a total of 39 SNP-trait associations while the single-trait analysis strategies BVSR
and sLMM identified 34 and 10 SNP-trait associations, respectively. In terms of the total
number of unique SNPs identified, VIMCO identified a smaller number of SNPs than BVSR;
9
Figure 3: Manhattan plots for the analysis results of VIMCO (first row), BVSR (second
row), and sLMM (last row), in the NFBC1966 study. In the first and second row, the
horizontal red lines correspond to a global FDR of 0.1. In the last row, the horizontal red
line corresponds to a p-value cut-off of 1.25 × 10−8. The number in the box indicates the
number of SNP associations identified for each trait.
VIMCO identified 23 SNPs to be associated with at least one trait, while BVSR and sLMM
identified 30 and 9 SNPs respectively. However, if we consider each trait separately, VIMCO
identified more SNPs than BVSR and sLMM for traits which showed strong correlation with
each other. For example, the strongest trait-trait correlation was observed between TC and
LDL and for TC, VIMCO identified 18 SNPs, while BVSR and sLMM identified 9 and 1
SNPs respectively; for LDL, VIMCO identified 16 SNPs, while BVSR and sLMM identified
14 and 2 SNPs respectively.
The lfdrs and p-values of identified SNPs by VIMCO and BVSR are given in Supple-
mentary Table C1. For SNPs that were identified by either VIMCO, BVSR or sLMM, we
also report their p-values from a multivariate linear mixed model (mvLMM) fitted using the
GEMMA package [20]. As noted earlier, mvLMM assesses a different but related hypothesis
of whether any of the 4 traits are associated with the genetic variants.
Analysis of the NFBC1966 dataset was conducted on a machine with 3.0 GHz Intel Xeon
CPU and 32G memory. With the BVSR estimates as initial values (1.2 hours), it took
VIMCO an additional 2.5 hours to complete the full variational inference procedure.
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3.2.2 SINDI
The SINDI dataset contains three eye measurements: the ratio of blood pressure to intraoc-
ular pressure (BP/IOP), central corneal thickness (CCT) and and vertical cup-to-disc ratio
(VCDR). These three traits are risk factors for glaucoma [10]. The pairwise correlation for
these three traits (Supplementary Figure C2) were much weaker than those observed for
the lipid traits in the NFBC1966 dataset, with the strongest correlation of 0.16 observed
between BP/IOP and CCT. After quality control following previous studies [6] and SNP
pruning, 2,219 individuals and 257,736 SNPs were available for analysis. Locations of SNPs
identified by VIMCO, BVSR and sLMM in the genome are shown in Figure 4. In this
dataset where the traits were weakly correlated, the performance for VIMCO was similar
as the single trait approaches. VIMCO and BVSR identified the same 2 SNPs to be associ-
ated with CCT. Among the two associations, rs12447690 was also identified by sLMM (the
p-value is 5.5×10−9). This SNP was located in the Zinc-Finger protein (ZNF469) gene, and
was previously reported to be associated with CCT [7]. The lfdrs and p-values of identified
SNPs are given in Supplementary Table C2.
Analysis of the SINDI dataset used BVSR estimates as initial values (6.8 hours), and
used an additional 1.2 hours to complete the full variational inference procedure.
4 Discussion
In this article, we have proposed a novel method VIMCO that allows an investigator to
identify the specific trait that is associated with the genetic loci when performing a joint
GWAS analysis of multiple traits. Results from simulations and real data analyses demon-
strate that VIMCO improved statistical power when the traits were correlated and had
comparable performance when the traits were not correlated, when compared with single-
trait analysis strategies. Furthermore, VIMCO utilizes a computationally efficient VBEM
algorithm which allows it to handle genome-wide genotype data efficiently. It is, however,
not without limitations. A limitation of VIMCO is that it is not applicable when the number
of traits analyzed exceeds the number of samples. With increasing interest in performing
phenome-wide association studies whereby the number of phenotypes can be larger than
the sample size, extending VIMCO to handle larger number of phenotypes is an avenue for
future work. Additionally, VIMCO requires individual-level trait and genotype data to be
collected from the same individuals. The development of a method where summary statistics
from different individuals can be used for analysis instead of individual-level data is another
avenue for future research.
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Figure 4: Manhattan plots for the analysis results of VIMCO (first row), BVSR (second row),
and sLMM (last row), in the SINDI study. In the first and second row, the horizontal red
lines correspond to a global FDR of 0.1. In the last row, the horizontal red line corresponds
to a p-value cut-off of 1.67 × 10−8. The number in the box indicates the number of SNP
associations identified for each trait.
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